Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 23, 2022
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s
Kristina M Brooks, Mauricio Pinilla, Alice M Stek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 22, 2016
Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial
Linda Barlow-Mosha, Konstantia Angelidou, Jane Lindsey, et al.
The Journal of Infectious Diseases
|
March 7, 2018
Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children
Ursula J Buchholz, Coleen K Cunningham, Petronella Muresan, et al.
The Journal of Infectious Diseases
|
November 24, 2019
Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Journal of Infectious Diseases
|
February 2, 2020
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2015
Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy
George K Siberry, Denise L Jacobson, Heidi J Kalkwarf, et al.
The Journal of Infectious Diseases
|
March 7, 2018
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Journal of Orthopaedic and Sports Physical Therapy
|
October 20, 2023
Up Front and Open? Shrouded in Secrecy? Or Somewhere in Between? A Meta-Research Systematic Review of Open Science Practices in Sport Medicine Research
Garrett S Bullock, Patrick Ward, Franco M Impellizzeri, et al.
AIDS (London, England)
|
November 30, 2020
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV
Kristina M Brooks, Jeremiah D Momper, Mauricio Pinilla, et al.
The Journal of Infectious Diseases
|
June 22, 2022
Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children
Coleen K Cunningham, Ruth A Karron, Petronella Muresan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 23, 2022
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s
Kristina M Brooks, Mauricio Pinilla, Alice M Stek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 22, 2016
Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial
Linda Barlow-Mosha, Konstantia Angelidou, Jane Lindsey, et al.
The Journal of Infectious Diseases
|
March 7, 2018
Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children
Ursula J Buchholz, Coleen K Cunningham, Petronella Muresan, et al.
The Journal of Infectious Diseases
|
November 24, 2019
Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Journal of Infectious Diseases
|
February 2, 2020
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2015
Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy
George K Siberry, Denise L Jacobson, Heidi J Kalkwarf, et al.
The Journal of Infectious Diseases
|
March 7, 2018
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Journal of Orthopaedic and Sports Physical Therapy
|
October 20, 2023
Up Front and Open? Shrouded in Secrecy? Or Somewhere in Between? A Meta-Research Systematic Review of Open Science Practices in Sport Medicine Research
Garrett S Bullock, Patrick Ward, Franco M Impellizzeri, et al.
AIDS (London, England)
|
November 30, 2020
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV
Kristina M Brooks, Jeremiah D Momper, Mauricio Pinilla, et al.
The Journal of Infectious Diseases
|
June 22, 2022
Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children
Coleen K Cunningham, Ruth A Karron, Petronella Muresan, et al.
Page
of 5